Celltrion Goes It Alone With First Solo US Biosimilar Launch

Vegzelma Is The Fourth FDA-Approved Bevacizumab Rival To Avastin

 
• By David Wallace
  
Celltrion_Magnified
Celltrion is striking out on its own with the launch of Vegzelma

More from Biosimilars

More from Products